A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers

ANALYTE_TYPES - Analyte Types (phv00437064.v1.p1)
BODY_SITE - Body site where sample was collected (phv00437063.v1.p1)
CLINICAL_RESPONSE - Clinical response to T cell therapy from the trial (phv00437057.v1.p1)
CONSENT - Consent group as determined by DAC (phv00437051.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00437066.v1.p1)
HPV_TYPE - Strain of HPV infection (phv00437061.v1.p1)
IS_TUMOR - Whether the sample is from a tumor (phv00437065.v1.p1)
PRIMARY_METASTATIC_TUMOR - Indicates whether sample is a primary tumor or metastasis (phv00437067.v1.p1)
PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00437068.v1.p1)
RESPONSE_DURATION - Duration of clinical response to the T cell therapy from the trial (phv00437058.v1.p1)
SAMPLE_ID - Sample ID (phv00437062.v1.p1)
SAMPLE_ID - Sample ID (phv00437054.v1.p1)
SUBJECT_ID - Subject ID (phv00437055.v1.p1)
SUBJECT_ID - Subject ID (phv00437050.v1.p1)
SUBJECT_ID - Subject ID (phv00437053.v1.p1)
TUMOR_STAGE - Tumor stage of sample (phv00437069.v1.p1)
TUMOR_TREATMENT - Type of tumor treatment for sample (phv00437070.v1.p1)